Bethesda, Maryland Saturday, March 15, 2025, 10:00 Hrs [IST] ...
Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback